DEFJ, LLC enters TRANSCODE THERAPEUTICS, INC. with 300.04K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/5/2026ACC: 0001104659-26-091074
300.04K
Baseline shares
100% direct
300.04K
Direct ownership
1 position
13.83M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned300.04K
Total
300.04K direct300.04K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 300.04K | Direct |
| Total | 300.04K | 300.04K direct |
Derivative Holdings2
Series A Non-Voting Convertible Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
11.81M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Series B Non-Voting Convertible Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
2.02M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
13.83M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Non-Voting Convertible Preferred Stock Direct | Common Stock | 0 | — | — | 11.81M | N/A |
| Series B Non-Voting Convertible Preferred Stock Direct | Common Stock | 0 | — | — | 2.02M | N/A |
| Total | 13.83M | 0.00 | ||||